All posts tagged "Adam Feuerstein"
-
1.1K3BiotechFeuerstein’s Flab on Northwest Bio (NWBO) Dives Stock on Meritless Claims After Nailing Primary Endpoint
Northwest Biotherapeutics (OTCMKTS: NWBO) is now a risk-off biotech trading at a significant discount; in a “sell the news” market, there are...
-
656BiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
582BiotechCytoDyn FDA Letter is Old News – International Still Progressing
CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...
-
5453BiotechCytoDyn Saves Lives & Reduces COVID-19 Hospital Duration
6 endpoints met after full data release so shorts double down on trial failure narrative Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...
-
8006BiotechLeronlimab Trial Results All But Certain Pointing to Approval For CytoDyn
CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
-
5921BiotechReddit Rebellion Targeting The Short Mafia Next
The BANG stocks (Blackberry (NYSE: BB), AMC Entertainment (NYSE: AMC), Nokia Inc. (NYSE: NOK), GameStop Corp (NYSE: GME) are experiencing wild pric...
-
24.8KBiotechSorrento Therapeutics Stock: Ignore Hindenburg
A thorn in the side of longs continues to be Hindenburg Research. Whenever a hot stock starts climbing, Hindenburg goes short and...
-
5962BiotechWading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...